Biomotion Sciences Warrant
SLXNW
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$0.02
FAIR PRICE
$0.02
MARGIN
$0.00
P/E Ratio
N/A
Div. Yield
N/A
ROE
-100.6%
Market Cap
$6843
Small-cap
COMING SOON
Get notified when SLXNW's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Ilan Hadar
COUNTRY
IL
HEADQUARTERS
Jerusalem
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate SLXNW's fair price
Biomotion Sciences Warrant's fair price of $0.02 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $0.02, SLXNW trades 25.0% below its calculated fair value.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting SLXNW's risk profile.
RELATIVE · 30%
Comparing SLXNW's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for SLXNW, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for SLXNW.
Explore on BuliosFAQ
What is the fair price of SLXNW?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Biomotion Sciences Warrant is $0.02. At the current market price of $0.02, SLXNW trades 25.0% below its calculated fair value.
Is SLXNW overvalued or undervalued?+
Biomotion Sciences Warrant is currently undervalued based on our valuation model. The stock trades at $0.02, which is 25.0% below the fair price of $0.02.
How often is SLXNW's fair price updated?+
We update fair price calculations for SLXNW daily after market close. The current fair price of $0.02 incorporates the latest market data and sector multiples.
What factors affect SLXNW's fair price calculation?+
SLXNW's fair price of $0.02 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight)., ROE of -100.6%.
Is SLXNW a good buy right now?+
At $0.02, SLXNW trades 25.0% below our fair value estimate of $0.02. The stock is currently undervalued. ROE stands at -100.6% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does SLXNW pay dividends?+
SLXNW does not currently pay a dividend.